Amiodarone is an antiarrhythmic medication used to treat and prevent a number of types of irregular heartbeats. This includes ventricular tachycardia (VT), ventricular fibrillation (VF), and wide complex tachycardia, as well as atrial fibrillation and paroxysmal supraventricular tachycardia.
This medicinal substance has been classified in the anatomical therapeutic chemical (ATC) classification according to its main therapeutic use as follows:
Competent medicine agencies globally have authorized commercialization of this active ingredient according to these medication package inserts (MPIs):
Amiodarone is the active ingredient of these drugs:
Ecuador
Hong Kong
South Africa
Australia
South Africa
Turkey
Brazil
Tunisia
Ecuador
Ecuador
Germany
Germany
Estonia Lithuania Poland
Brazil
South Africa
Brazil
Australia New Zealand
South Africa
South Africa
Brazil Ecuador
Brazil
Cyprus
Turkey
Australia Ecuador Estonia Finland France
Singapore
South Africa
New Zealand
Turkey
United States
Poland
United States
Tunisia
Australia
Turkey
Austria Tunisia
Spain